07/08 2017
  Cool off
DEAR _t.e.s.t_@beispiel.com,
it´s time to celebrate summer and cool off your burning budgets.
We invite you to take part in our survey, in return we might offer next times the products you liked.
Start this 2 minute survey now.

Coming Soon

We are happy that in the upcoming weeks we will launch or new website. Keep your eyes open and let us know how you like it...

PELOAcademy: FREE Webinar

Flat biology is out: Gain Fresh Insights on your Drug Candidates on 3D Cell Culture in vitro Systems

Date: Tue, July 11, 2017
Time: 4 PM (CEST)
presented by Angel Garcia Martin, StemTek Therapeutics

Sign up now here. Don´t have time on Tuesday? Sign up anyway and we will send you the record asap.

Cancer is the number one cause of death in the developed world, expected to increase in the next decades. For advanced cancer, survival rates have remained steady for the last 30 years. Only about 10% of the compounds progress successfully through clinical development. Many drugs fail during clinical trials, especially during phase III, which is the most expensive phase of clinical development...

Read more and sign up here

Get fresh insights with Angel Garcia Martin, PhD, MBA, CEO StemTek Therapeutics
If you would like to be removed from our mailing list, click here to unsubscribe:

PELOBIOTECH GmbH, Dr. Peter Frost, Am Klopferspitz 19, 82152 Planegg, Bavaria, Germany

  HRB 197203

Email Marketing by ActiveCampaign